← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2008First marketed drug
Mar 13, 2013First NDA
Mar 13, 2013Last known activity
Mar 2, 2022
Acquired by Devicor Medical Products → Leica → Danaher on Jan 1, 2011
Timeline
1980s
- Jun 1, 1983
Navidea Biopharmaceuticals— Founded
2000s
- Jul 1, 2005
Danaher— Now
2010s
- Jan 1, 2011
Devicor Medical Products— Acquired By
- Mar 13, 2013
tc99m-tilmanocept— NDA Organization
Drugs by trial phase (5 distinct, 20 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Indications
Approved for
Studied for
- Alzheimer Disease
- Arthritis
- Arthritis, Rheumatoid
- Breast Neoplasms
- Carcinoma
- Carcinoma, Squamous Cell
- Cognitive Dysfunction
- Colorectal Neoplasms
- Dementia
- Fatty Liver
- Liver Neoplasms
- Melanoma
- Neoplasm Metastasis
- Neoplasms, Second Primary
- Non-alcoholic Fatty Liver Disease
- Parkinson Disease
- Sarcoma
- Sarcoma, Kaposi
- Squamous Cell Carcinoma of Head and Neck
- Syndrome
Marketed drugs (1)
Recent trials (38)
- NCT05246280Study directorPhase 3Mar 2, 2022
- NCT05246280Lead sponsorPhase 3Mar 2, 2022
- NCT04947137Study directorPhase 2May 12, 2021
- NCT04947137Lead sponsorPhase 2May 12, 2021
- NCT04078191Study directorPhase 2Dec 31, 2019
- NCT04078191Lead sponsorPhase 2Dec 31, 2019
- NCT03938636Lead sponsorPhase 2Apr 8, 2019
- NCT03938636Study directorPhase 2Apr 8, 2019
- NCT03332940Study directorPhase 1Dec 6, 2017
- NCT03332940Lead sponsorPhase 1Dec 6, 2017
- NCT03241446Lead sponsorPhase 1Sep 30, 2017
- NCT03157167Overall official - principal investigatorEarly Phase 1Jul 15, 2017
- NCT03157167Lead sponsorEarly Phase 1Jul 15, 2017
- NCT03029988Lead sponsorPhase 1May 1, 2017
- NCT03029988Overall official - principal investigatorPhase 1May 1, 2017
Details
- Founded
- Dublin, OH, US Jun 1, 1983
- First NDA
- Mar 13, 2013
- Last known activity
- Mar 2, 2022